Trial · NCT00829686
Trial of Antibiotic Treatment for Skin Abscess in Patients at Risk for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
NCT00829686, Not applicable, Completed, 59th Medical Wing; results first posted 2009-07-28
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Trial of Antibiotic Treatment for Skin Abscess in Patients at Risk for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection. Trials, record NCT00829686. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00829686
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Trial of Antibiotic Treatment for Skin Abscess in Patients at Risk for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
- NCT number
- NCT00829686
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 31 participants, actual
- Lead sponsor
- 59th Medical Wing
- Conditions
- Abscess
- Interventions
- Septra
- First posted
- 2009-01-27
- Last updated
- 2017-06-09
- Results first posted
- 2009-07-28
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinical Improvement at 7 Days After Incision and Drainage | 7 days | improving wound without evidence of fever, worsening cellulitis or induration |
| Secondary | Recurrence Rates | 30 days | recurrence of abscess in previous or new location within 30 days |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Clinical Improvement at 7 Days After Incision and Drainage | 7 days | participants | NUMBER | |
| SECONDARY | Recurrence Rates | 30 days | participants | NUMBER |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Clinical Improvement at 7 Days After Incision and Drainage | No Intervention | 10 | participants | ||
| Clinical Improvement at 7 Days After Incision and Drainage | Septra DS | 14 | participants | ||
| Recurrence Rates | No Intervention | 1 | participants | ||
| Recurrence Rates | Septra DS | 0 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | No Intervention | 13 | |
| Overall Study | STARTED | Septra DS | 18 | |
| Overall Study | COMPLETED | No Intervention | 13 | |
| Overall Study | COMPLETED | Septra DS | 18 | |
| Overall Study | NOT COMPLETED | No Intervention | 0 | |
| Overall Study | NOT COMPLETED | Septra DS | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Septra DS vs No Intervention: Clinical Improvement at 7 Days After Incision and Drainage | Trial comparisons |
| Septra DS vs No Intervention: Recurrence Rates | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00829686
GET https://conductscience.org/api/trials/v1/NCT00829686/registered